(Q24629455)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Quantifying heterogeneity in a meta-analysis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Meta-analysis in clinical trials

7 April 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

7 April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Optimal provision of needle and syringe programmes for injecting drug users: A systematic review

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis

7 April 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

7 April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Expected increase in prevalence of HCV-related cirrhosis and its complications in the United States: no effect of current antiviral treatment coverage?

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Is sexual contact a major mode of hepatitis C virus transmission?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

A trial to reduce hepatitis C seroincidence in drug users

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Hepatitis C virus evasion of adaptive immune responses: a model for viral persistence

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

The HCV Synthesis Project: scope, methodology, and preliminary results

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

The effectiveness of behavioural interventions in the primary prevention of hepatitis C amongst injecting drug users: a randomised controlled trial and lessons learned

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

How can hepatitis C be prevented in the long term?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

High hepatitis C virus prevalence and incidence among Canadian intravenous drug users

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Public injecting and the need for 'safer environment interventions' in the reduction of drug-related harm

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

A review of the evidence for the effectiveness of primary prevention interventions for hepatitis C among injecting drug users

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Changes in risk behavior and dynamics of hepatitis C virus infections among young drug users in Amsterdam, the Netherlands

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Retrospective cohort study examining incidence of HIV and hepatitis C infection among injecting drug users in Dublin

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Sexual activity as a risk factor for hepatitis C.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Volunteer bias in nonrandomized evaluations of the efficacy of needle-exchange programs

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

On the need for the rare disease assumption in case-control studies

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Quantitative methods in the review of epidemiologic literature

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Incidence of hepatitis C in drug injectors: the role of homelessness, opiate substitution treatment, equipment sharing, and community size

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

High hepatitis C incidence in new injecting drug users: a policy failure?

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of France

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Cumulative incidence of hepatitis C seroconversion in a cohort of seronegative injecting drug users

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Methadone maintenance and hepatitis C virus infection among injecting drug users

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

An improper use of statistical significance testing in studying covariables.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105033

Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: final report from a longitudinal study

30 May 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR196

Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR196

HCV reinfection studies and the door to vaccine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR196

The impact of injecting drug use status on hepatitis C-related referral and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR196

Intranasal transmission of hepatitis C virus: virological and clinical evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR196

Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR196

Harm reduction, hepatitis C and opioid pharmacotherapy: an opportunity for integrated hepatitis C virus-specific harm reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR196

A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR196

Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR196

Hepatitis C virus incidence among injecting drug users on opioid replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR196

Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR196

Does Bleach Disinfection of Syringes Help Prevent Hepatitis C Virus Transmission?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR196

Hepatitis C virus seroconversion among young injection drug users: relationships and risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR196

A certain fate: Spread of HIV among young injecting drug users in Manipur, North-East India

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR196

Sharing of drug preparation equipment as a risk factor for hepatitis C

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21628661

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21628661

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Incidence rate and risk factors for HCV seroconversion among injecting drug users in an area with low HIV seroprevalence

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21628661

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/INFDIS/JIR196

1 reference

1 reference

1 reference

PubMed publication ID

21628661

1 reference